TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -4 | 0 | 20 | -15 | -14 | -33 | -9 |
| S | %wins | 50 | 50 | 50 | 50 | 50 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/20 19:26 | 2/28/20 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tubridy Karen L | MA | O | SVP,Chie | S.d | -30 | 8.70 | 0 | -3 | -4 | 85 | D | ||||||||||||||
6/29/16 16:16 | 6/27/16 | EBIO | Eleven Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tubridy Karen L | MA | O | Chief De | S | -9 | 2.08 | 9 | -4 | -12 | 33 | D | -85 | -31 | -34 | 524 | 76 | 6 | -17 | -15 | -11 | 8 | 129 | 60 | 9 | |
12/30/15 16:04 | 12/28/15 | EBIO | Eleven Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tubridy Karen L | MA | O | Chief De | S | -13 | 2.85 | 0 | -4 | -12 | 33 | D | -75 | 3 | 17 | 6 | 5 | 4 | -3 | 3 | -8 | -89 | -89 | -36 | -33 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |